Co-organizers Technology Portfolio

Co-organizers Technology Portfolio Login

NRC Institute for Biological Sciences (NRC-IBS) Technology Portfolio
ID #	Title	PDF	Video	Information Request
NRC-IBS 12075	Molecular Imaging Reagents Capable of Multi-Modal Imaging Applications for Cancer
NRC-IBS 12033	Engineered Biosynthetic Pathway for Sialic Acid Analogs and its Use for the Development of Anti-Infective
NRC-IBS 11894	F. Tularensis, or Components Thereof, for AllergicAirway Disorder Therapy
NRC-IBS 11784	Semi-Synthetic Glyco-Lipid Compositions Derived from Archaebacteria with a Superior Adjuvant Effect
NRC-IBS 11749	Anti-Apoptotic Antibodies
NRC-IBS 11686	Humanized Soluble VH and VL Single-Domain Antibody Librariesfor Developing Human Therapeutic Applications
NRC-IBS 11630	Novel Peptide for the Treatment of Alzheimer's Disease
NRC-IBS 11627	Cancer Applications of Novel Anti-Angiogenic Peptides with a Pleiotropic Effect, and Their Molecular Target
NRC-IBS 11305	Mycobacterial Lipids for Use in Vaccine-Delivery Liposomes with an Adjuvant Effect
NRC-IBS 11085	Vector Technology to Deliver Neurotherapeutics across the Blood Brain Barrier